HCA Healthcare stockholders re-elect nine directors, approve stock plan and officer exculpation
At its April 24, 2025 annual meeting, HCA Healthcare stockholders elected all nine director nominees, approved an amendment adding 13,150,000 shares to the 2020 Stock Incentive Plan, and approved an amendment to the charter allowing officer exculpation under Delaware law. All three stockholder proposals placed before the meeting were rejected, and the Board approved a 2025-2026 director compensation program.
Key points
- Stock incentive plan amendment adds 13,150,000 shares and extends the plan term to April 24, 2035.
- Officer exculpation charter amendment was approved and takes effect April 25, 2025.
- Ernst & Young LLP was ratified as auditor for 2025 with 207,353,356 votes for and 20,631,138 against.
- Three stockholder proposals on golden parachutes, Patient Safety committee charter, and acquisition strategy were not approved.
The filing
Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 29, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.